Reduction of plasma clot stability by a novel factor XIIIa inhibitor from the Giant Amazon Leech, Haementeria ghilianii.
The blood-sucking leech, Haementeria ghilianii, has evolved a number of agents that attenuate haemostasis. Recently we have isolated a potent inhibitor of factor XIIIa, tridegin, in the salivary glands which is almost certainly involved in feeding. Addition of purified natural tridegin to plasma, prior to clotting with thrombin, results in clots that deform more readily as adjudged by the greatly reduced development of the storage modulus on application of a shear force. The increase in the storage modulus in developing plasma clots is a slow process and continues for many hours. The effect of tridegin is particularly great when the clots are permitted to age in this way, demonstrating the role of factor XIIIa in the process. The IC50 for this inhibition is 138 ng/ml. Clots formed in the presence of tridegin are also lysed more rapidly in vitro by the leech's own fibrinolytic enzyme, hementin (time for 50% lysis, 16.0 +/- 0.8 h versus 22.3 +/- 2.0 h, P < 0.05). The synergy with which these agents act together may provide lessons for therapy of thrombosis in man.
Wallis
R B
RB
Biopharm (UK) Ltd, Hendy, Dyfed.
Seale
L
L
Finney
S
S
Sawyer
R T
RT
Bennett
G M
GM
Ross-Murphy
S B
SB
D000818:Animals; D001777:Blood Coagulation / Q000187:drug effects*; D005343:Fibrinolytic Agents / Q000494:pharmacology*; D006801:Humans; D007865:Leeches / Q000378:metabolism*; D012471:Salivary Proteins and Peptides / Q000494:pharmacology*; D011503:Transglutaminases / Q000037:antagonists & inhibitors*
D005343:Fibrinolytic Agents; D012471:Salivary Proteins and Peptides; C106835:tridegin; D011503:Transglutaminases